A carregar...
Metabolic assessment of a novel chronic myelogenous leukemic cell line and an imatinib resistant subline by (1)H NMR spectroscopy
The goal of this study was to examine metabolic differences between a novel chronic myelogenous leukemic (CML) cell line, MyL, and a sub-clone, MyL-R, which displays enhanced resistance to the targeted Bcr-Abl tyrosine kinase inhibitor imatinib. (1)H nuclear magnetic resonance (NMR) spectroscopy was...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2899017/ https://ncbi.nlm.nih.gov/pubmed/20676217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11306-010-0204-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|